nMSC and SEC therapies improve diastolic function in HFpEF through distinct remodeling mechanisms converging on T reg -mediated immune modulation. VIPcell supported identification of causal regulators, highlighting T reg -related signaling as a key driver of myocardial recovery in HFpEF. These findings offer mechanistic insight into cellular therapies for HFpEF and support the development of targeted, T reg -focused interventions.
Building similarity graph...
Analyzing shared references across papers
Loading...
Zhi-Dong Ge
Jonghyeuk Han
Felipe Takaesu
Northwestern University
Emory University
University of Maryland, Baltimore
Building similarity graph...
Analyzing shared references across papers
Loading...
Ge et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69a75f5fc6e9836116a2ab4b — DOI: https://doi.org/10.64898/2026.01.29.702616
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: